Down 42% in six months, why are investors putting the boot into this FTSE 250 icon?

It’s been six months since I last looked at the investment case for this FTSE 250 legend. Since then, its shares have continued to slide. What’s going on?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

A front-view shot of a multi-ethnic family with two children walking down a city street on a cold December night.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

In August 2023, I noticed that an insider had recently bought £400k of stock in Dr Martens (LSE:DOCS), the FTSE 250 footwear brand.

Kenny Wilson, the chief executive, paid 129p a share for his stake.

Six months later, the company’s share price is now around 88p, and he’s sitting on a paper loss of approximately £127k.

Since floating in February 2021, the stock has lost 80% of its value.

A difficult period

The apparent gloom surrounding the share price reflects a declining top line, particularly in North America, which is adversely impacting earnings.

In November 2023, the directors admitted trading had been “mixed“.

In January 2024, they reported December sales as being “softer” than expected and described the retail environment as “volatile“.

These are words that investors don’t like.

The company’s final results for the year ended 31 March 2023 (FY23) disclosed revenue of £1bn, and a profit before tax (PBT) of £159m.

Analysts are not expecting sales to return to this level until FY26.

Reduced earnings

However, by then, PBT is forecast to be 16% lower at £134m.

The consensus forecast is for earnings per share (EPS) of 8p in FY24, 8.9p in FY25, and 10.2p in FY26.

Although this shows an improving trend, all are a long way behind the 12.9p achieved in FY23.

No sales growth for 2023-2026 — and a 21% reduction in EPS — doesn’t make a great investment case.

Improving margins

But Dr Martens has one thing going for it that’s difficult to value — its brand. I think it’s fair to say that it’s a British icon.

However, this can only be pushed so far.

In common with all manufacturers, the company has faced a significant increase in its production costs since the pandemic.

But despite this, it’s managed to increase its gross profit margin from 59.7% (FY20), to 64.4% (six months to 30 September 2023).

This suggests it’s been increasing its prices by quite a lot.

Looking at its website, its original eight-hole boot is now selling for £170. When it was launched in 1960, it was priced at £2 (equivalent to £58 in 2024).

At first glance, an improving margin seems like a good thing. Raising the price of a pair of boots and making more from each pair sold, is a retailer’s dream.

But as a consequence, it’s selling fewer boots and shoes than previously — 5.7m during the first six months of its 2024 financial year, compared to 6.3m for the same period a year earlier.

If further price increases are implemented, customers may go elsewhere.

To put things in perspective, LVMH, which owns ultra-expensive luxury brands like Dior, Givenchy and Bulgari, achieved a gross profit margin of 68.8%, in 2023.

That’s only a few percentage points higher than Dr Martens, whose products were originally worn by factory workers.

I think the company needs to decide whether its products are for ‘the masses’ or a high-end fashion item.

All this means it’s caught in a vicious cycle of increasing prices to improves its profits, but then having to implement further price rises as sales volumes fall.

I don’t think this is sustainable.

For this reason, I wouldn’t want to invest at the moment.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

James Beard has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing For Beginners

After getting promoted from the FTSE 250, what’s next for Hiscox?

Jon Smith mulls over the latest reshuffle in the FTSE 250 and explains why he feels this top stock could…

Read more »

Investing Articles

Want dividend yields up to 9.9%? Here’s 3 FTSE 100 and FTSE 250 shares to consider

Looking to turbocharge your passive income? These high dividend yield FTSE 100 and FTSE 250 stocks could be just what…

Read more »

Investing Articles

2 shares absolutely crushing the FTSE 100 in 2024!

Not all FTSE 100 stocks are sleepy and meandering. This duo has surged more than four times higher than the…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Growth Shares

The FTSE 100 could hit 9,000 points by year end. Here’s why

Jon Smith talks through some factors that could help to lift the FTSE 100 to a new all-time high and…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

I’d seriously consider buying this UK technology small-cap stock today

Today's positive trading figures and a runway of growth potential ahead make this small-cap stock look attractive to me now.

Read more »

Investing Articles

It’s October! Does this mean UK stocks are going to crash?

Whisper it quietly, but four of the five biggest one-day falls in the FTSE 100 have been in the month…

Read more »

Investing Articles

With new nuclear energy deals in view, Rolls-Royce’s share price looks cheap to me anywhere under £11.48

Rolls-Royce’s share price dipped after a problem on a Cathay Pacific flight but has now bounced back on positive news…

Read more »

Investing Articles

Is the Greggs share price now a screaming buy for me after falling 10% this month?

Harvey Jones watched the Greggs share price climb and climb, but decided it was too expensive for him. Should he…

Read more »